GSPT1-specific protein degradation is effective in preclinical models of chemoresistant MYCN-amplified neuroblastoma
BACKGROUND: High-risk neuroblastoma (HR-NB) is associated with therapy-resistant relapse, and novel therapeutic strategies are needed. GSPT1 is a GTPase involved in protein translation whose disruption may offer therapeutic potential in translation-dependent cancers.METHODS: GSPT1 expression was assessed in publicly available clinical data and tissue microarrays. GSPT1-degrading molecular glues we
